ConductScience.org, home

Paper37213670

Synergistic Effect of Metformin and Lansoprazole Against Gastric Cancer through Growth Inhibition.

Kao HW and 2 others. Int J Med Sci, 2023. Cited by 4 papers, by iCite.

Cite this record

ConductScience Library. Synergistic Effect of Metformin and Lansoprazole Against Gastric Cancer through Growth Inhibition. Papers, record 37213670. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/37213670

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Synergistic Effect of Metformin and Lansoprazole Against Gastric Cancer through Growth Inhibition.
PubMed
Journal
Int J Med Sci
PubMed
Year
2023
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
4
iCite
Relative citation ratio, by iCite
0.52
iCite
Revised in PubMed
2023-05-24
PubMed

Authors3

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Kao HWHsiao-Wei
2Tsai KWKuo-Wang
3Lin WCWen-Chang

Source PubMed

Download CSV of authors

Topics7

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
MetforminMajor topic
Stomach NeoplasmsMajor topic
Diabetes Mellitus, Type 2Major topic
Animals
Humans
Lansoprazole
Proton Pump Inhibitors

Source PubMed

Download CSV of topics

References41

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
118006801Targeting vacuolar H+-ATPases as a new strategy against cancer.Cancer Res2007https://conductscience.org/library/papers/18006801PubMed
228388576Proton pump inhibitor ilaprazole suppresses cancer growth by targeting T-cell-originated protein kinase.Oncotarget2017https://conductscience.org/library/papers/28388576PubMed
321694841An update on the use of pantoprazole as a treatment for gastroesophageal reflux disease.Clin Exp Gastroenterol2010https://conductscience.org/library/papers/21694841PubMed
423151022In vitro and in vivo anti-tumor effect of metformin as a novel therapeutic agent in human oral squamous cell carcinoma.BMC Cancer2012https://conductscience.org/library/papers/23151022PubMed
527762303AKT/GSK3β signaling pathway is critically involved in human pluripotent stem cell survival.Sci Rep2016https://conductscience.org/library/papers/27762303PubMed
628126011Metformin targets multiple signaling pathways in cancer.Chin J Cancer2017https://conductscience.org/library/papers/28126011PubMed
724820971S100A8 contributes to drug resistance by promoting autophagy in leukemia cells.PLoS One2014https://conductscience.org/library/papers/24820971PubMed
818228389Determining cell cycle stages by flow cytometry.Curr Protoc Cell Biol2001https://conductscience.org/library/papers/18228389PubMed
921415163Metformin decreases the dose of chemotherapy for prolonging tumor remission in mouse xenografts involving multiple cancer cell types.Cancer Res2011https://conductscience.org/library/papers/21415163PubMed
1024802401Lansoprazole induces apoptosis of breast cancer cells through inhibition of intracellular proton extrusion.Biochem Biophys Res Commun2014https://conductscience.org/library/papers/24802401PubMed
1121226640Sorafenib: activity and clinical application in patients with hepatocellular carcinoma.Expert Opin Pharmacother2011https://conductscience.org/library/papers/21226640PubMed
1226351208Combined Use of Metformin and Everolimus Is Synergistic in the Treatment of Breast Cancer Cells.Oncol Res2014https://conductscience.org/library/papers/26351208PubMed
1320108024Biological and clinical significance of KRAS mutations in lung cancer: an oncogenic driver that contrasts with EGFR mutation.Cancer Metastasis Rev2010https://conductscience.org/library/papers/20108024PubMed
1432246720SynergyFinder 2.0: visual analytics of multi-drug combination synergies.Nucleic Acids Res2020https://conductscience.org/library/papers/32246720PubMed
1532214849Anticancer Effects of Antihypertensive L-Type Calcium Channel Blockers on Chemoresistant Lung Cancer Cells via Autophagy and Apoptosis.Cancer Manag Res2020https://conductscience.org/library/papers/32214849PubMed
1621705069
National, regional, and global trends in fasting plasma glucose and diabetes prevalence since 1980: systematic analysis of health examination surveys and epidemiological studies with 370 country-years and 2·7 million participants.
Lancet2011https://conductscience.org/library/papers/21705069PubMed
1733959611Lansoprazole Alone or in Combination With Gefitinib Shows Antitumor Activity Against Non-small Cell Lung Cancer A549 Cells in vitro and in vivo.Front Cell Dev Biol2021https://conductscience.org/library/papers/33959611PubMed
1818212742The antidiabetic drug metformin exerts an antitumoral effect in vitro and in vivo through a decrease of cyclin D1 level.Oncogene2008https://conductscience.org/library/papers/18212742PubMed
1924963109Metformin and cancer: mounting evidence against an association.Diabetes Care2014https://conductscience.org/library/papers/24963109PubMed
2024482380V-ATPase inhibition regulates anoikis resistance and metastasis of cancer cells.Mol Cancer Ther2014https://conductscience.org/library/papers/24482380PubMed

See all 41 referencesDownload CSV of references

Cited by4

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 4 citations.

PMIDTitleJournalYearIn PapersSource
42712908Repurposing of lansoprazole and nitazoxanide as NR2F2 inhibitors in the gastric cancer cell line GCIY: computational insights and siRNA-mediated in vitro tests.Front Chem2026https://conductscience.org/library/papers/42712908PubMed
41882204Synergistic induction of apoptosis by the epigenetic modulator decitabine and metformin in gastric cancer cells highlights the potential for combination therapy.Sci Rep2026https://conductscience.org/library/papers/41882204PubMed
40207763Metformin and its Nanoformulations in Cancer Prevention and Therapy.Curr Pharm Des2025https://conductscience.org/library/papers/40207763PubMed
38192437Antibacterial and Immunoregulatory Effects of Metformin against Helicobacter pylori Infection in Rat Model.Biomed Res Int2023https://conductscience.org/library/papers/38192437PubMed

Download CSV of cited by

Genes17

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/37213670

GET https://conductscience.org/api/papers/v1/37213670/references?page=2